Nxstage Medical Inc Sentiment Increases on Better Stock Potential

April 17, 2018 - By Adrian Mccoy

Nxstage Medical, Inc. (NASDAQ:NXTM) Logo

Sentiment for Nxstage Medical Inc (NASDAQ:NXTM)

Nxstage Medical Inc (NASDAQ:NXTM) institutional sentiment increased to 1.25 in Q4 2017. Its up 0.34, from 0.91 in 2017Q3. The ratio is more positive, as 79 funds increased and opened new equity positions, while 63 cut down and sold their equity positions in Nxstage Medical Inc. The funds in our partner’s database now have: 47.78 million shares, down from 51.56 million shares in 2017Q3. Also, the number of funds holding Nxstage Medical Inc in their top 10 equity positions increased from 3 to 7 for an increase of 4. Sold All: 22 Reduced: 41 Increased: 48 New Position: 31.

NxStage Medical, Inc., a medical technology company, develops, makes, and markets services and products for patients suffering from chronic or acute kidney failure. The company has market cap of $1.72 billion. The Company’s primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. It currently has negative earnings. The firm operates through three divisions: System One, In-Center, and Services.

The stock increased 0.57% or $0.147 during the last trading session, reaching $25.947. About 24,681 shares traded. Nxstage Medical, Inc. (NASDAQ:NXTM) has declined 9.81% since April 17, 2017 and is downtrending. It has underperformed by 21.36% the S&P500.

Burren Capital Advisors Ltd holds 4.82% of its portfolio in Nxstage Medical, Inc. for 33,550 shares. Falcon Edge Capital Lp owns 791,000 shares or 4.39% of their US portfolio. Moreover, Pennant Capital Management Llc has 3.86% invested in the company for 1.76 million shares. The New Jersey-based Alpine Associates Management Inc. has invested 3.5% in the stock. Dafna Capital Management Llc, a California-based fund reported 216,119 shares.#img1#

Since January 1, 0001, it had 0 buys, and 4 selling transactions for $379,835 activity.

Nxstage Medical, Inc. (NASDAQ:NXTM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: